Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (151-160 of 596) with videos related to

Pageof 60
Sort By:
Haematologica|November 10, 2018
Detection and characterization of homozygosity of mutated <i>CALR</i> by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high <i>CALR</i> mutation loads or with progressive diseaseAnna Stengel, Sabine Jeromin, Torsten Haferlach, et al.
Journal of Cancer Research and Clinical Oncology|March 31, 2019
Impact of 9q deletions on the classification of patients with acute myeloid leukemiaBettina Balk, Torsten Haferlach, Manja Meggendorfer, et al.
Annals of Hematology|September 1, 2005
Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patientsUlrike Bacher, Wolfgang Kern, Susanne Schnittger, et al.
Annals of Hematology|May 6, 2009
Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN categoryUlrike Bacher, Susanne Schnittger, Wolfgang Kern, et al.
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|June 5, 2024
Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classificationClaudia Haferlach, German Ott, Katharina Hörst, et al.
Cancer Genetics and Cytogenetics|May 15, 2007
A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemiaUlrike Bacher, Torsten Haferlach, Wolfgang Kern, et al.
Haematologica|January 3, 2012
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemiaEnrico Tiacci, Vera Grossmann, Maria Paola Martelli, et al.
Haematologica|January 7, 2017
Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and <i>de novo</i> acute myeloid leukemiaPedro Martin-Cabrera, Sabine Jeromin, Karolína Perglerovà, et al.
Haematologica|June 1, 2005
Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent eventsGerhard Herzog, Juxian Lu-Hesselmann, Yvonne Zimmermann, et al.
Haematologica|October 16, 2025
Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case studyBirte Kristin Jung, Sandra Weißmann, Caroline Schock, et al.
Pageof 60

Showing results (151-160 of 596) with videos related to

Sort By:
Pageof 60
Haematologica|November 10, 2018
Detection and characterization of homozygosity of mutated <i>CALR</i> by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high <i>CALR</i> mutation loads or with progressive diseaseAnna Stengel, Sabine Jeromin, Torsten Haferlach, et al.
Journal of Cancer Research and Clinical Oncology|March 31, 2019
Impact of 9q deletions on the classification of patients with acute myeloid leukemiaBettina Balk, Torsten Haferlach, Manja Meggendorfer, et al.
Annals of Hematology|September 1, 2005
Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patientsUlrike Bacher, Wolfgang Kern, Susanne Schnittger, et al.
Annals of Hematology|May 6, 2009
Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN categoryUlrike Bacher, Susanne Schnittger, Wolfgang Kern, et al.
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|June 5, 2024
Overview on WHO-HAEM5 and the diagnostic relevance of genetic alterations for the classificationClaudia Haferlach, German Ott, Katharina Hörst, et al.
Cancer Genetics and Cytogenetics|May 15, 2007
A case of chronic myeloproliferative syndrome followed by precursor T-cell acute lymphoblastic leukemiaUlrike Bacher, Torsten Haferlach, Wolfgang Kern, et al.
Haematologica|January 3, 2012
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemiaEnrico Tiacci, Vera Grossmann, Maria Paola Martelli, et al.
Haematologica|January 7, 2017
Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and <i>de novo</i> acute myeloid leukemiaPedro Martin-Cabrera, Sabine Jeromin, Karolína Perglerovà, et al.
Haematologica|June 1, 2005
Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent eventsGerhard Herzog, Juxian Lu-Hesselmann, Yvonne Zimmermann, et al.
Haematologica|October 16, 2025
Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case studyBirte Kristin Jung, Sandra Weißmann, Caroline Schock, et al.
Pageof 60